ACE-话题@MedSci

#ACE#

496篇内容 | 2888人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1656108, encodeId=24ca165610859, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=J Clin Oncol：选择性雌激素受体降解剂（Elacestrant）对比标准内分泌治疗ER+/HR-晚期乳腺癌的疗效：III期临床研究EMERALD, objectType=article, longId=727795, objectId=19a7e27795a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19a7e27795a3, replyNumber=0, likeNumber=86, createdTime=2023-03-10, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19a7e27795a3, moduleTitle=J Clin Oncol：选择性雌激素受体降解剂（Elacestrant）对比标准内分泌治疗ER+/HR-晚期乳腺癌的疗效：III期临床研究EMERALD, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19a7e27795a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656120, encodeId=05d71656120b0, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Investigative Radiology：基于锥形束CT扫描的TACE术后药物剂量的空间预测, objectType=article, longId=737604, objectId=c3c5e3760468, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3c5e3760468, replyNumber=0, likeNumber=81, createdTime=2022-11-11, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3c5e3760468, moduleTitle=Investigative Radiology：基于锥形束CT扫描的TACE术后药物剂量的空间预测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3c5e3760468)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656091, encodeId=28b2165609199, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Front Oncol：TACE联合ICIs+TKIs治疗不可切除肝细胞癌的疗效, objectType=article, longId=294112, objectId=1b49294112ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b49294112ae, replyNumber=0, likeNumber=94, createdTime=2022-09-16, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b49294112ae, moduleTitle=Front Oncol：TACE联合ICIs+TKIs治疗不可切除肝细胞癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b49294112ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656122, encodeId=9fea1656122c9, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=ACEI和ARB降压药，是否能降低老年抑郁症发病风险？, objectType=article, longId=739209, objectId=d496e3920959, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d496e3920959, replyNumber=0, likeNumber=79, createdTime=2023-07-05, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d496e3920959, moduleTitle=ACEI和ARB降压药，是否能降低老年抑郁症发病风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d496e3920959)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656076, encodeId=7aa616560e6ee, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Hypertension：基于ACEI和CCB的治疗或与中高风险高血压患者更好的血压控制有关, objectType=article, longId=218085, objectId=3d5a21808537, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d5a21808537, replyNumber=0, likeNumber=93, createdTime=2022-01-22, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d5a21808537, moduleTitle=Hypertension：基于ACEI和CCB的治疗或与中高风险高血压患者更好的血压控制有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d5a21808537)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656088, encodeId=b85a165608841, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Front Oncol：立体定向放疗（SBRT）联合免疫治疗（SBRT-IO）对比TACE治疗局部进展期肝细胞癌患者的疗效, objectType=article, longId=264987, objectId=306f26498e26, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=306f26498e26, replyNumber=0, likeNumber=91, createdTime=2022-07-25, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=306f26498e26, moduleTitle=Front Oncol：立体定向放疗（SBRT）联合免疫治疗（SBRT-IO）对比TACE治疗局部进展期肝细胞癌患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=306f26498e26)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656086, encodeId=235616560866d, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Nuclear-translocation of ACLY induced by obesity-related factors enhances pyrimidine metabolism through regulating histone acetylation in endometrial cancer, objectType=article, longId=221045, objectId=9e8a22104543, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e8a22104543, replyNumber=0, likeNumber=81, createdTime=2022-02-23, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e8a22104543, moduleTitle=Nuclear-translocation of ACLY induced by obesity-related factors enhances pyrimidine metabolism through regulating histone acetylation in endometrial cancer, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e8a22104543)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656074, encodeId=268516560e4b4, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Liver Cnacer：腹腔镜肝切除对比经皮射频消融治疗小肝癌的疗效对比, objectType=article, longId=217958, objectId=642521e958f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=642521e958f7, replyNumber=0, likeNumber=78, createdTime=2022-05-13, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=642521e958f7, moduleTitle=Liver Cnacer：腹腔镜肝切除对比经皮射频消融治疗小肝癌的疗效对比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=642521e958f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656077, encodeId=7a0b16560e747, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Cardiovasc Diabeto：2型糖尿病肾病多因素干预对死亡率和MACE的影响, objectType=article, longId=218238, objectId=779121823886, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=779121823886, replyNumber=0, likeNumber=60, createdTime=2022-06-23, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=779121823886, moduleTitle=Cardiovasc Diabeto：2型糖尿病肾病多因素干预对死亡率和MACE的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=779121823886)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656106, encodeId=4fc6165610618, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=J Clin Oncol：Elacestrant vs 标准内分泌疗法治疗ER+/HER2-晚期乳腺癌, objectType=article, longId=727470, objectId=49e6e27470b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49e6e27470b5, replyNumber=0, likeNumber=85, createdTime=2023-01-07, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49e6e27470b5, moduleTitle=J Clin Oncol：Elacestrant vs 标准内分泌疗法治疗ER+/HER2-晚期乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=49e6e27470b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656090, encodeId=6a8e1656090c5, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Front Oncol：TACE联合仑伐替尼(TACE- L) vs TACE联合索拉非尼(TACE- S)治疗肝细胞癌(HCC)伴有门静脉癌栓(PVTT)患者的疗效和安全性, objectType=article, longId=292954, objectId=a2d3292954c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2d3292954c0, replyNumber=0, likeNumber=79, createdTime=2022-09-14, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2d3292954c0, moduleTitle=Front Oncol：TACE联合仑伐替尼(TACE- L) vs TACE联合索拉非尼(TACE- S)治疗肝细胞癌(HCC)伴有门静脉癌栓(PVTT)患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a2d3292954c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656069, encodeId=1ba41656069ea, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Journal of Extracellular Vesicles：瞿介明教授团队首次验证：雾化吸入异体人源间充质基质细胞外囊泡的临床前有效性及临床安全性, objectType=article, longId=216518, objectId=8a1521651806, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a1521651806, replyNumber=0, likeNumber=72, createdTime=2022-03-17, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a1521651806, moduleTitle=Journal of Extracellular Vesicles：瞿介明教授团队首次验证：雾化吸入异体人源间充质基质细胞外囊泡的临床前有效性及临床安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a1521651806)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656107, encodeId=fecd165610e8c, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=JAHA：ACEi/ARB与COVID-19住院患者结局之间的关系, objectType=article, longId=265016, objectId=07d9265016b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07d9265016b5, replyNumber=0, likeNumber=98, createdTime=2021-12-26, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07d9265016b5, moduleTitle=JAHA：ACEi/ARB与COVID-19住院患者结局之间的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=07d9265016b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656065, encodeId=93e716560659f, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Colloids and Surfaces B：MTX+HCQ纳米胶束是传统给药方式疗效的3倍, objectType=article, longId=215556, objectId=a2d221555631, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2d221555631, replyNumber=0, likeNumber=79, createdTime=2021-08-19, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2d221555631, moduleTitle=Colloids and Surfaces B：MTX+HCQ纳米胶束是传统给药方式疗效的3倍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a2d221555631)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656087, encodeId=db75165608ec7, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Liver Cancer：影像学应答是伴有肉眼血管侵犯(MVI)的晚期肝细胞癌患者应用TACE+RT治疗时的显著预后指标, objectType=article, longId=221712, objectId=37eb221e1225, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37eb221e1225, replyNumber=0, likeNumber=85, createdTime=2022-11-04, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37eb221e1225, moduleTitle=Liver Cancer：影像学应答是伴有肉眼血管侵犯(MVI)的晚期肝细胞癌患者应用TACE+RT治疗时的显著预后指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37eb221e1225)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656097, encodeId=c5af165609e04, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Liver Cancer：Lenvatinib(仑伐替尼)初始治疗出现应答是仑伐替尼（LEN)+经动脉化疗栓塞(LEN-TACE)序贯治疗的预后指标, objectType=article, longId=299284, objectId=0f55299284f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f55299284f7, replyNumber=0, likeNumber=63, createdTime=2022-12-27, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f55299284f7, moduleTitle=Liver Cancer：Lenvatinib(仑伐替尼)初始治疗出现应答是仑伐替尼（LEN)+经动脉化疗栓塞(LEN-TACE)序贯治疗的预后指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f55299284f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656071, encodeId=ac4016560e14e, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=J Extracell Vesicles：瞿介明教授采用同种异体脂肪间充质细胞来源细胞外囊泡治疗ARDS的临床前研究, objectType=article, longId=217343, objectId=773521e34386, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=773521e34386, replyNumber=0, likeNumber=101, createdTime=2021-11-22, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=773521e34386, moduleTitle=J Extracell Vesicles：瞿介明教授采用同种异体脂肪间充质细胞来源细胞外囊泡治疗ARDS的临床前研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=773521e34386)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656089, encodeId=55ca16560891e, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Eur Heart J：BBs和ACEI/ARBs用于预防乳腺癌患者因蒽环类药物或曲妥珠单抗引起的左心室功能障碍, objectType=article, longId=292762, objectId=e405292e62f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e405292e62f8, replyNumber=0, likeNumber=93, createdTime=2022-09-01, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e405292e62f8, moduleTitle=Eur Heart J：BBs和ACEI/ARBs用于预防乳腺癌患者因蒽环类药物或曲妥珠单抗引起的左心室功能障碍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e405292e62f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656082, encodeId=4232165608263, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Front Oncol：肝切除术(HR)对比TACE治疗中期肝细胞癌(IM-HCC)的疗效, objectType=article, longId=219491, objectId=16ac219491e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16ac219491e4, replyNumber=0, likeNumber=0, createdTime=2022-06-28, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16ac219491e4, moduleTitle=Front Oncol：肝切除术(HR)对比TACE治疗中期肝细胞癌(IM-HCC)的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16ac219491e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656072, encodeId=932d16560e239, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Liver Cnacer：BCLC 0/A期肝细胞癌根治性切除术后使用富马酸替诺福韦酯(TDF)预防复发优于恩替卡韦（ETV）, objectType=article, longId=217476, objectId=486321e47658, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=486321e47658, replyNumber=0, likeNumber=138, createdTime=2022-05-29, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=486321e47658, moduleTitle=Liver Cnacer：BCLC 0/A期肝细胞癌根治性切除术后使用富马酸替诺福韦酯(TDF)预防复发优于恩替卡韦（ETV）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=486321e47658)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ACE

2020-05-29

shanyongle (审核中...)

前往app查看评论内容

#ACE#

J Clin Oncol：选择性雌激素受体降解剂（Elacestrant）对比标准内分泌治疗ER+/HR-晚期乳腺癌的疗效：III期临床研究EMERALD

2023-03-10

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Investigative Radiology：基于锥形束CT扫描的TACE术后药物剂量的空间预测

2022-11-11

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Front Oncol：TACE联合ICIs+TKIs治疗不可切除肝细胞癌的疗效

2022-09-16

shanyongle (审核中...)

前往app查看评论内容

#ACE#

ACEI和ARB降压药，是否能降低老年抑郁症发病风险？

2023-07-05

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Hypertension：基于ACEI和CCB的治疗或与中高风险高血压患者更好的血压控制有关

2022-01-22

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Front Oncol：立体定向放疗（SBRT）联合免疫治疗（SBRT-IO）对比TACE治疗局部进展期肝细胞癌患者的疗效

2022-07-25

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Nuclear-translocation of ACLY induced by obesity-related factors enhances pyrimidine metabolism through regulating histone acetylation in endometrial cancer

2022-02-23

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Liver Cnacer：腹腔镜肝切除对比经皮射频消融治疗小肝癌的疗效对比

2022-05-13

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Cardiovasc Diabeto：2型糖尿病肾病多因素干预对死亡率和MACE的影响

2022-06-23

shanyongle (审核中...)

前往app查看评论内容

#ACE#

J Clin Oncol：Elacestrant vs 标准内分泌疗法治疗ER+/HER2-晚期乳腺癌

2023-01-07

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Front Oncol：TACE联合仑伐替尼(TACE- L) vs TACE联合索拉非尼(TACE- S)治疗肝细胞癌(HCC)伴有门静脉癌栓(PVTT)患者的疗效和安全性

2022-09-14

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Journal of Extracellular Vesicles：瞿介明教授团队首次验证：雾化吸入异体人源间充质基质细胞外囊泡的临床前有效性及临床安全性

2022-03-17

shanyongle (审核中...)

前往app查看评论内容

#ACE#

JAHA：ACEi/ARB与COVID-19住院患者结局之间的关系

2021-12-26

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Colloids and Surfaces B：MTX+HCQ纳米胶束是传统给药方式疗效的3倍

2021-08-19

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Liver Cancer：影像学应答是伴有肉眼血管侵犯(MVI)的晚期肝细胞癌患者应用TACE+RT治疗时的显著预后指标

2022-11-04

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Liver Cancer：Lenvatinib(仑伐替尼)初始治疗出现应答是仑伐替尼（LEN)+经动脉化疗栓塞(LEN-TACE)序贯治疗的预后指标

2022-12-27

shanyongle (审核中...)

前往app查看评论内容

#ACE#

J Extracell Vesicles：瞿介明教授采用同种异体脂肪间充质细胞来源细胞外囊泡治疗ARDS的临床前研究

2021-11-22

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Eur Heart J：BBs和ACEI/ARBs用于预防乳腺癌患者因蒽环类药物或曲妥珠单抗引起的左心室功能障碍

2022-09-01

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Front Oncol：肝切除术(HR)对比TACE治疗中期肝细胞癌(IM-HCC)的疗效

2022-06-28

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Liver Cnacer：BCLC 0/A期肝细胞癌根治性切除术后使用富马酸替诺福韦酯(TDF)预防复发优于恩替卡韦（ETV）

2022-05-29

科室
- - 订阅+
  - 更多科室
工具
服务